Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Petrol Diesel Prices
Char Dham Yatra
Gyanvapi Mosque
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / WHO expert panel to discuss COVAXIN approval in meet today
India

WHO expert panel to discuss COVAXIN approval in meet today

WHO expert panel to discuss COVAXIN approval in meet today
Written by Sagar
Oct 05, 2021, 10:40 am 2 min read
WHO expert panel to discuss COVAXIN approval in meet today
A WHO expert panel will discuss COVAXIN's approval in a meet today.

COVAXIN, India's indigenous vaccine against the coronavirus, will likely receive the much-awaited approval from the World Health Organization (WHO) this month. An expert panel of the global health body is expected to meet on Tuesday to take a call on the vaccine's emergency authorization, according to documents detailing the group's agenda for the meeting. Here are more details on this.

Meet
Strategic Advisory Group of Expert to meet today

The Strategic Advisory Group of Expert on Immunization (SAGE) will hold a meeting on Tuesday to discuss COVAXIN's long-pending approval. The committee had started its four-day meet on policy guidance on Monday. All vaccine candidates submitted to WHO must be approved by SAGE and a technical advisory group, which will also meet this month, for Emergency Use Listing (EUL).

Vaccine
COVAXIN's approval marred by delays over insufficient data

COVAXIN, developed by Bharat Biotech, was India's first approved indigenous coronavirus vaccine and has been found nearly 78% effective. Its approval by WHO has been pending for several months, marred by delays over insufficient trial data. In June, the United States Food and Drug Administration (FDA) had also rejected its application for an emergency use approval.

Significance
WHO approval important for wider global acceptance

As and when COVAXIN receives WHO's nod, it will gain a wider acceptance around the world. International recognition will allow Bharat Biotech to start widely exporting its vaccine and become part of the "vaccine passport" - under which fully vaccinated people are allowed to travel abroad without facing restrictions. Notably, many Indians, who received this vaccine, have been facing issues in traveling abroad.

Other vaccines
WHO has so far approved 7 vaccines

WHO has so far given its EUL to seven COVID-19 vaccines. They are the Pfizer-BioNTech vaccine, the Johnson and Johnson (J&J) vaccine, two versions of the Oxford-AstraZeneca vaccine, Moderna's shot, and China's Sinopharm and Sinovac vaccines. The EUL is a risk-based procedure that considers vaccines for assessment and listing. The process also includes therapeutics and in-vitro diagnostics.

Quote
'World is in need of vaccines, timely approval is key'

"Globally, the world is in need of vaccines and we have to ensure that this is a global war, and many countries are still not getting vaccinated," said Dr. Naveet Wig, chairperson of the COVID-19 task force at the All India Institute of Medical Sciences (AIIMS) in New Delhi. "So we have to ensure that our vaccines should get the approval timely."

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Sagar
Sagar
Twitter
Sagar covers national news for NewsBytes. He has previously worked as an editorial intern at NDTV. Over the course of his near three-year career, Sagar has gained experience in news writing, copy editing, and video production. He holds a Bachelor's degree in Journalism and Mass Communication from the University of Delhi.
Latest
World Health Organization
Coronavirus
COVID-19
COVID-19 Vaccine
COVAXIN
Related
Latest
'The Gray Man' trailer: Evans-Gosling play chase game, Dhanush appears
'The Gray Man' trailer: Evans-Gosling play chase game, Dhanush appears Entertainment
US: 19 children among 21 killed in Texas school shooting
US: 19 children among 21 killed in Texas school shooting World
Pagani C10 spied testing; to be unveiled this September
Pagani C10 spied testing; to be unveiled this September Auto
Geek Pride Day: 5 signs you are a geek!
Geek Pride Day: 5 signs you are a geek! Lifestyle
Volkswagen Touareg EDITION 20 breaks cover: Check features
Volkswagen Touareg EDITION 20 breaks cover: Check features Auto
World Health Organization
COVID-19 re-emergence: Saudi bans travel to India, 15 other countries
COVID-19 re-emergence: Saudi bans travel to India, 15 other countries World
'Concerned' WHO expects more monkeypox cases globally
'Concerned' WHO expects more monkeypox cases globally World
North Korea: 8,20,620 fresh COVID-19 cases in just 3 days
North Korea: 8,20,620 fresh COVID-19 cases in just 3 days World
North Korea reports 6 COVID-19 deaths, isolates 1,87,800 people
North Korea reports 6 COVID-19 deaths, isolates 1,87,800 people World
North Korea confirms first COVID-19 case ever, imposes nationwide lockdown
North Korea confirms first COVID-19 case ever, imposes nationwide lockdown World
More News
Coronavirus
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
COVID-19 vaccine precautionary dose available for 18+ from April 10
COVID-19 vaccine precautionary dose available for 18+ from April 10 India
COVID-19 survivors at risk of developing serious blood clots: Study
COVID-19 survivors at risk of developing serious blood clots: Study Technology
COVID-19: India reports 1,660 new cases, 4,100 more deaths
COVID-19: India reports 1,660 new cases, 4,100 more deaths India
More News
COVID-19
COVID-19: India logs 1,675 fresh cases, 31 more deaths
COVID-19: India logs 1,675 fresh cases, 31 more deaths India
Pandemic created a billionaire every 30 hours: Oxfam at Davos
Pandemic created a billionaire every 30 hours: Oxfam at Davos World
First cases of new Omicron subvariants detected in India
First cases of new Omicron subvariants detected in India India
COVID-19: India reports 2,022 fresh cases, 46 more deaths
COVID-19: India reports 2,022 fresh cases, 46 more deaths India
Woman, daughters found dead in Delhi; chilling note found
Woman, daughters found dead in Delhi; chilling note found India
More News
COVID-19 Vaccine
COVID-19: India logs 2,927 new cases; 32 more deaths
COVID-19: India logs 2,927 new cases; 32 more deaths India
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
Government considering COVID-19 booster dose for all adults: Report
Government considering COVID-19 booster dose for all adults: Report India
COVID-19 vaccination for 12-14 years begins; here's how to register
COVID-19 vaccination for 12-14 years begins; here's how to register India
COVID-19 vaccination for 12-14-year-olds to start from Wednesday: Details here
COVID-19 vaccination for 12-14-year-olds to start from Wednesday: Details here India
More News
COVAXIN
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension India
COVAXIN likely to get approval for children above 2yrs: Report
COVAXIN likely to get approval for children above 2yrs: Report India
COVID-19: China fighting worst outbreak, UK sets new high
COVID-19: China fighting worst outbreak, UK sets new high World
COVAXIN, Covishield will now be available in hospitals and clinics
COVAXIN, Covishield will now be available in hospitals and clinics India
COVAXIN supply to be increased as teens get COVID-19 vaccines
COVAXIN supply to be increased as teens get COVID-19 vaccines India
More News
Related
Australia accepts COVAXIN as 'recognized' vaccine for incoming travelers
Australia accepts COVAXIN as 'recognized' vaccine for incoming travelers World
Cannot cut corners, thorough evaluation needed for COVAXIN EUL: WHO
Cannot cut corners, thorough evaluation needed for COVAXIN EUL: WHO India
COVAXIN trial data for children aged 2-18 submitted to DCGI
COVAXIN trial data for children aged 2-18 submitted to DCGI India
Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October
Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October India
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022